Mesenchymal stem cell therapy in skin: why and what for?
Open Access
- 21 March 2013
- journal article
- review article
- Published by Wiley in Experimental Dermatology
- Vol. 22 (5) , 307-310
Abstract
In recent years, few stem cells have gained as much clinical notoriety as mesenchymal stem cells. Indeed, MSCs are already in use for a range of systemic inflammatory and autoimmune conditions that also affect the skin, such as acute and chronic graft versus host disease or lupus erythematosus. Most interestingly, these cells are able to improve skin wound healing in multiple preclinical models and few patient series. An additional potential of these cells is the delivery of missing structural elements in skin inherited disorders. However, we here contend that MSCs are not appropriate for cell replacement therapies in the context of wound healing. Indeed, engraftment of cells in the dermis is poor in the absence of irradiation and the observed effects seem mainly due to paracrine factors. In this viewpoint, we favour the hypothesis of a replete niche and competition with resident mesenchymal populations in the dermis not allowing the engraftment of newly delivered MSCs. Consequently, we propose that the benefit of MSCs may be at least in part reproduced by the growth factors or immunomodulatory molecules that they produce. In any case, the rapid progress in this field has allowed the emergence of important questions in skin biology that need to be addressed in parallel with the predictable future use of MSCs in the clinic.Keywords
This publication has 109 references indexed in Scilit:
- Clonal Growth of Dermal Papilla Cells in Hydrogels Reveals Intrinsic Differences between Sox2-Positive and -Negative Cells In Vitro and In VivoJournal of Investigative Dermatology, 2012
- Human Dermis Harbors Distinct Mesenchymal Stromal Cell SubsetsJournal of Investigative Dermatology, 2012
- Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept studyThe Lancet Neurology, 2012
- Human Mesenchymal Stem Cells Reprogram Adult Cardiomyocytes Toward a Progenitor-Like State Through Partial Cell Fusion and Mitochondria TransferStem Cells, 2011
- De Novo Production of Dermal Papilla Cells during the Anagen Phase of the Hair CycleJournal of Investigative Dermatology, 2010
- Human Gingiva-Derived Mesenchymal Stem Cells Elicit Polarization of M2 Macrophages and Enhance Cutaneous Wound HealingStem Cells, 2010
- β-catenin Activity in the Dermal Papilla Regulates Morphogenesis and Regeneration of HairDevelopmental Cell, 2010
- SKPs Derive from Hair Follicle Precursors and Exhibit Properties of Adult Dermal Stem CellsCell Stem Cell, 2009
- A Perivascular Origin for Mesenchymal Stem Cells in Multiple Human OrgansCell Stem Cell, 2008
- Epidermal insulin/IGF‐1 signalling control interfollicular morphogenesis and proliferative potential through Rac activationThe EMBO Journal, 2008